Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZEVALIN safely and effectively. See full prescribing information for ZEVALIN. ZEVALIN® (ibritumomab tiuxetan) injection, for intravenous use Initial U.S. Approval: 2002
Medication labelWhy this: Advisory · dailymed-prescription
Zevalin is indicated for the treatment of adult patients with relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL). Zevalin is indicated for the treatment of previously untreated follicular NHL in adult patients who achieve a partial or complete response to first-line chemotherapy.
- generic_name
- ibritumomab tiuxetan
- product_names
- ibritumomab tiuxetan
- ndc
- 72893-007, 72893-007-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en